Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities
| RNA Name | Mechanism of Action | Effect on Cancer | Reference |
|---|---|---|---|
|
USP2-AS1
lncRNA |
Part of a prognostic 2-lncRNA signature (BCCuS) impacting copper-induced cell death pathways | Predicts breast cancer prognosis and immune dysfunction | PMID: 36699089 |
External Database SearchDetailed Information
RNA Name:
USP2-AS1
Mechanism of Action:
Part of a prognostic 2-lncRNA signature (BCCuS) impacting copper-induced cell death pathways
Effect on Cancer:
Predicts breast cancer prognosis and immune dysfunction
PMID:
36699089
|
|||
|
NIFK-AS1
lncRNA |
Works in conjunction with USP2-AS1 in the BCCuS signature | Predicts sensitivity to therapies and patient survival | PMID: 36699089 |
External Database SearchDetailed Information
RNA Name:
NIFK-AS1
Mechanism of Action:
Works in conjunction with USP2-AS1 in the BCCuS signature
Effect on Cancer:
Predicts sensitivity to therapies and patient survival
PMID:
36699089
|
|||
|
C6orf99
lncRNA |
Regulates DLD mRNA via miR-370-3p and miR-432-5p in the cuproptosis pathway | Associated with endocrine therapy resistance in ER+ BC | PMID: 37143115 |
External Database SearchDetailed Information
RNA Name:
C6orf99
Mechanism of Action:
Regulates DLD mRNA via miR-370-3p and miR-432-5p in the cuproptosis pathway
Effect on Cancer:
Associated with endocrine therapy resistance in ER+ BC
PMID:
37143115
|
|||
|
CARMN
lncRNA |
Involved in the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network | Regulates PRNP in cuproptosis in breast cancer | PMID: 36980514 |
External Database SearchDetailed Information
RNA Name:
CARMN
Mechanism of Action:
Involved in the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network
Effect on Cancer:
Regulates PRNP in cuproptosis in breast cancer
PMID:
36980514
|
|||
|
LINC01863
lncRNA |
Impacts cell proliferation in BC, associated with drug sensitivity | Role in immune infiltration and therapeutic responses | PMID: 38772805 |
External Database SearchDetailed Information
RNA Name:
LINC01863
Mechanism of Action:
Impacts cell proliferation in BC, associated with drug sensitivity
Effect on Cancer:
Role in immune infiltration and therapeutic responses
PMID:
38772805
|
|||
|
AC104211.1
lncRNA |
Similar role as LINC01863, influencing BC cell viability and sensitivity to therapies | Prognostic and therapeutic implications | PMID: 38772805 |
External Database SearchDetailed Information
RNA Name:
AC104211.1
Mechanism of Action:
Similar role as LINC01863, influencing BC cell viability and sensitivity to therapies
Effect on Cancer:
Prognostic and therapeutic implications
PMID:
38772805
|
|||
|
MEG3
lncRNA |
Activates NLRP3/caspase-1/GSDMD pathway to induce pyroptosis | Anti-tumor effect in triple-negative breast cancer (TNBC) by inducing pyroptosis | PMID: 34326697 |
External Database SearchDetailed Information
RNA Name:
MEG3
Mechanism of Action:
Activates NLRP3/caspase-1/GSDMD pathway to induce pyroptosis
Effect on Cancer:
Anti-tumor effect in triple-negative breast cancer (TNBC) by inducing pyroptosis
PMID:
34326697
|
|||
|
Malat1
lncRNA |
Suppresses pyroptosis and T cell-mediated killing by inducing SERPINB6B | Promotes tumor initiation, metastasis, and immune evasion | PMID: 38195932 |
External Database SearchDetailed Information
RNA Name:
Malat1
Mechanism of Action:
Suppresses pyroptosis and T cell-mediated killing by inducing SERPINB6B
Effect on Cancer:
Promotes tumor initiation, metastasis, and immune evasion
PMID:
38195932
|
|||
|
8 pyroptosis-related lncRNAs 0.0, AC004585.1, DLGAP1-AS1, TNFRSF14-AS1, AL606834.2, Z68871.1, AC009119.1, LINC01871, AL136368.1
lncRNA |
Risk model assessing immune infiltration and tumor microenvironment interactions | Prognostic and therapeutic potential in breast cancer | PMID: 35702100 |
External Database SearchDetailed Information
RNA Name:
8 pyroptosis-related lncRNAs 0.0, AC004585.1, DLGAP1-AS1, TNFRSF14-AS1, AL606834.2, Z68871.1, AC009119.1, LINC01871, AL136368.1
Mechanism of Action:
Risk model assessing immune infiltration and tumor microenvironment interactions
Effect on Cancer:
Prognostic and therapeutic potential in breast cancer
PMID:
35702100
|
|||
|
RP11-459E5.1, RP11-1070N10.3, RP11-817J15.3
lncRNA |
Identified via risk model correlating with immune checkpoints and mutation burden | High correlation with survival outcomes | PMID: 35360412 |
External Database SearchDetailed Information
RNA Name:
RP11-459E5.1, RP11-1070N10.3, RP11-817J15.3
Mechanism of Action:
Identified via risk model correlating with immune checkpoints and mutation burden
Effect on Cancer:
High correlation with survival outcomes
PMID:
35360412
|
|||